Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing…

India growth – ‘Investors have given up on India, but…’: financial expert weighs on India’s PMI vs US PMI

The Composite flash Purchasing Managers’ Index (PMI) experienced a quicker growth in February after three consecutive quarters of softening, a…